Hospital Universitario Ramón y Cajal; Pharmacy

Madrid 28034

0 studies enrolling now · 1 studies all time

What they study most

Malignant Melanoma

Studies at this site

• Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma — Completed